Pulmonary Fibrosis Clinical Trials

A listing of Pulmonary Fibrosis medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Birmingham Alabama 35294

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

Birmingham Alabama 35294

A clinical research study for the treatment of Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

Birmingham Alabama 35294-0006

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Birmingham Alabama 35294

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Arizona

UPDATED

Phoenix Arizona 85006

Patients are needed to participate in a clinical research study evaluating SAR156597 and placebo for the treatment of Idiopathic Pulmonary Fibrosis

UPDATED

Scottsdale Arizona 85259

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

UPDATED

Tucson Arizona 85723

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Phoenix Arizona 85013

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

California

UPDATED

La Jolla California 92093

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Los Angeles California 90024

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

Los Angeles California 90073

A clinical research study for the treatment of Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

Los Angeles California 90048

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Los Angeles California 90095

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

View More ▼

Los Angeles California 90095-1690

A clinical trial seeking patients for a research study for the treatment of Pulmonary Arterial Hypertension, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease or Pulmonary Hypertension

Los Angeles California 90024

A clinical trial to evaluate treatments using Adempas, Riociguat (BAY63-2521) and Placebo for patients with Idiopathic Interstitial Pneumonias / Hypertension, Pulmonary

Los Angeles California 90095

Patients are needed to participate in a clinical research study evaluating treprostinil for the treatment of Pulmonary Arterial Hypertension, Interstitial Lung Disease or Idiopathic Pulmonary Fibrosis

Los Angeles California 90095-1690

Patients are needed to participate in a clinical research study of bosentan and No specific intervention to evaluate Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

Los Angeles California 90095-1690

Patients are needed to participate in a clinical research study of bosentan and No specific intervention to evaluate Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

Los Angeles California 90024

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Palo Alto California 94305

A clinical trial seeking patients for a research study for the treatment of Idiopathic Pulmonary Fibrosis (IPF) or Persistent Cough

Sacramento California 95817

A clinical research study for the treatment of Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

Sacramento California 95817

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

San Francisco California 94143

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

San Francisco California 94143

A clinical trial to evaluate treatments using Adempas, Riociguat (BAY63-2521) and Placebo for patients with Idiopathic Interstitial Pneumonias / Hypertension, Pulmonary

Stanford California 94305

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

Stanford California 94305-5236

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Colorado

UPDATED

Denver Colorado 80206

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

UPDATED

Wheat Ridge Colorado 80033

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Aurora Colorado 80045

A clinical trial to evaluate treatments using Adempas, Riociguat (BAY63-2521) and Placebo for patients with Idiopathic Interstitial Pneumonias / Hypertension, Pulmonary

Aurora Colorado 80045

Patients are needed to participate in a clinical research study evaluating Plerixafor mobilization of autologous CD117 stem cells for the treatment of COPD, Cystic Fibrosis or Pulmonary Fibrosis

Denver Colorado 80206

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

View More ▼

Denver Colorado 80206

A clinical research study for the treatment of Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

Denver Colorado 80206

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Denver Colorado 80206

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Connecticut

UPDATED

New Haven Connecticut 06520

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Danbury Connecticut

A Phase 4 clinical study for patients with Idiopathic Pulmonary Fibrosis

Hartford Connecticut 06102

A clinical trial to evaluate treatments using Ceftolozane/Tazobactam for patients with Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation or Pseudomonas Aeruginosa Infection

New Haven Connecticut 06520

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

New Haven Connecticut 06511

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

View More ▼

New Haven Connecticut 06520

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Florida

UPDATED

Jacksonville Florida 32224

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

UPDATED

Jacksonville Florida 32209

Patients are needed to participate in a clinical research study evaluating SAR156597 and placebo for the treatment of Idiopathic Pulmonary Fibrosis

UPDATED

Miami Florida 33136

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

UPDATED

Orlando Florida 32803

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

UPDATED

Sarasota Florida 34239

Patients are needed to participate in a clinical research study of Nintedanib and Pirfenidone to evaluate Idiopathic Pulmonary Fibrosis

View More ▼

UPDATED

Wellington Florida 33414

Patients are needed to participate in a clinical research study evaluating SAR156597 and placebo for the treatment of Idiopathic Pulmonary Fibrosis

UPDATED

Weston Florida 33331

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Daytona Beach Florida 32117

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Gainesville Florida 32610-0225

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis